Hematology Treatment Protocols
Browse approved Five Minute Hematology treatment-protocol references and open each protocol in 5MH Tools.
Blinatumomab
Acute Lymphoblastic Leukemia · Agent protocol
Hyper-CVAD
Acute Lymphoblastic Leukemia · Adaptive regimen
Inotuzumab Ozogamicin
Acute Lymphoblastic Leukemia · Agent protocol
Mini-Hyper-CVD + fractionated Inotuzumab → Blinatumomab (MD Anderson post-2017 amendment)
Acute Lymphoblastic Leukemia · Adaptive regimen
7+3
Acute Myeloid Leukemia · Regimen
Azacitidine + Venetoclax
Acute Myeloid Leukemia · Adaptive regimen
CLAG-M
Acute Myeloid Leukemia · Regimen
DEC10-VEN
Acute Myeloid Leukemia · Adaptive regimen
DEC5-VEN
Acute Myeloid Leukemia · Adaptive regimen
FLAG-IDA
Acute Myeloid Leukemia · Regimen
High-dose Cytarabine
Acute Myeloid Leukemia · Regimen
Intermediate-dose Cytarabine
Acute Myeloid Leukemia · Regimen
Axicabtagene ciloleucel
Cellular Therapy · Cellular therapy
Brexucabtagene autoleucel
Cellular Therapy · Cellular therapy
Ciltacabtagene autoleucel
Cellular Therapy · Cellular therapy
Idecabtagene vicleucel
Cellular Therapy · Cellular therapy
Lisocabtagene maraleucel
Cellular Therapy · Cellular therapy
Tisagenlecleucel
Cellular Therapy · Cellular therapy
ABVD
Hodgkin Lymphoma · Adaptive regimen
BrECADD
Hodgkin Lymphoma · Adaptive regimen
Nivolumab + AVD
Hodgkin Lymphoma · Regimen
Bendamustine + Rituximab
Lymphoma · Regimen
DA-EPOCH-R
Lymphoma · Adaptive regimen
DHAOx ± Rituximab
Lymphoma · Regimen
DHAP ? Rituximab
Lymphoma · Regimen
GDP ? Rituximab
Lymphoma · Regimen
GemOx ? Rituximab
Lymphoma · Regimen
ICE ? Rituximab
Lymphoma · Regimen
Pola-R-CHP
Lymphoma · Regimen
R-CHOP-21
Lymphoma · Regimen
Belantamab Mafodotin + Pd
Multiple Myeloma · Regimen
Belantamab Mafodotin + Vd
Multiple Myeloma · Regimen
CED
Multiple Myeloma · Regimen
Dara-Kd (CANDOR)
Multiple Myeloma · Regimen
Dara-Rd (POLLUX)
Multiple Myeloma · Regimen
Dara-VRd (PERSEUS, transplant eligible)
Multiple Myeloma · Regimen
Dara-VTD (CASSIOPEIA)
Multiple Myeloma · Regimen
DCEP
Multiple Myeloma · Regimen
Isatuximab + Kd
Multiple Myeloma · Regimen
Isatuximab + VRd - Transplant Eligible
Multiple Myeloma · Regimen
KPd
Multiple Myeloma · Regimen
KRd
Multiple Myeloma · Regimen
VCD / CyBorD (weekly 28-day)
Multiple Myeloma · Regimen
VD-PACE
Multiple Myeloma · Regimen
VRd
Multiple Myeloma · Regimen
VTD
Multiple Myeloma · Regimen
VTD-PACE
Multiple Myeloma · Regimen
Belantamab Mafodotin — product administration / ocular management
Targeted Therapy · Agent protocol
Elranatamab
Targeted Therapy · Agent protocol
Talquetamab
Targeted Therapy · Agent protocol
Teclistamab
Targeted Therapy · Agent protocol
Teclistamab + Daratumumab
Targeted Therapy · Regimen
BEAM
Transplant · Conditioning
BuCy (Bu16/Cy120)
Transplant · Conditioning
CBV
Transplant · Conditioning
Cy-TBI
Transplant · Conditioning
FluBu3
Transplant · Conditioning
FluBu4
Transplant · Conditioning
FluMel140
Transplant · Conditioning
Melphalan 140
Transplant · Conditioning
Melphalan 200
Transplant · Conditioning
TBF3 (Thiotepa-Busulfan-Fludarabine)
Transplant · Conditioning